You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBOC 201

Showing 1 - 25 of 306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anemia Severe Trial in Pittsburgh (HBOC-201)

Available
  • Anemia Severe
  • HBOC-201
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
May 16, 2022

Anemia Trial in Miami (HBOC-201)

Available
  • Anemia
  • HBOC-201
  • Miami, Florida
    Jackson Memorial Hospital
Nov 10, 2021

Anemia Trial in Baltimore (HBOC-201)

Available
  • Anemia
  • HBOC-201
  • Baltimore, Maryland
    The Johns Hopkins Hospital
Sep 27, 2021

Anemia Trial in Englewood (HBOC-201)

Enrolling by invitation
  • Anemia
  • HBOC-201
  • Englewood, New Jersey
    Englewood Hospital and Medical Center
Aug 16, 2021

Hereditary Cancer, Breast Cancer, Ovarian Cancer Trial in Switzerland (Adapted Family Gene Toolkit, Targeted intervention)

Recruiting
  • Hereditary Cancer
  • +2 more
  • Adapted Family Gene Toolkit
  • Targeted intervention
  • Delémont, Jura, Switzerland
  • +7 more
Nov 12, 2022

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Growth Hormone Deficiency Trial (LUM-201)

Not yet recruiting
  • Growth Hormone Deficiency
  • (no location specified)
Apr 5, 2023

Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning

Recruiting
  • Idiopathic Inflammatory Myopathy
  • +3 more
  • CAB-201 following preconditioning with fludarabine and cyclophosphamide
  • Orange, California
    University of California Irvine
Nov 30, 2023

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • CABA-201
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 7, 2023

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))

Recruiting
  • Growth Hormone Deficiency
  • LUM-201
  • rhGH Norditropin® pen (34 µg/kg)
  • Birmingham, Alabama
  • +52 more
Jan 30, 2023

Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

Not yet recruiting
  • Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
  • IncobotulinumtoxinA
  • Placebo
  • (no location specified)
Oct 13, 2023

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)

Recruiting
  • Uveal Melanoma
  • Metastatic
  • 4.7 microCi 225Ac-MTI-201
  • +11 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022

Chronic Low-back Pain, Degenerative Disc Disease Trial in Miami (CELZ-201-DDT, Placebo)

Not yet recruiting
  • Chronic Low-back Pain
  • Degenerative Disc Disease
  • Miami, Florida
    University of Miami
Sep 25, 2023

X-linked Retinoschisis Trial (ATSN-201)

Not yet recruiting
  • X-linked Retinoschisis
  • ATSN-201
  • (no location specified)
May 26, 2023

Platysma Prominence Trial in United States (NT 201, NT 201 Placebo)

Recruiting
  • Platysma Prominence
  • NT 201
  • NT 201 Placebo
  • Washington, District of Columbia
  • +3 more
Mar 23, 2023

Pulmonary Arterial Hypertension Trial in Worldwide (Oral zamicastat)

Completed
  • Pulmonary Arterial Hypertension
  • Oral zamicastat
  • Linz, Austria
  • +10 more
Aug 18, 2023

Atopic Dermatitis Trial in China (CBP-201)

Not yet recruiting
  • Atopic Dermatitis
  • Beijing, Beijing, China
  • +40 more
Jun 14, 2023

Solid Tumor, Advanced Solid Tumor Trial (PYX-201)

Not yet recruiting
  • Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Feb 9, 2023

Enlarged Pores, Sebum Production Trial in Los Angeles, Nashville (NT 201, Placebo)

Recruiting
  • Enlarged Pores
  • Sebum Production
  • NT 201
  • Placebo
  • Los Angeles, California
  • +1 more
Mar 24, 2023

Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 Trial in Worldwide (BMN 190,

Completed
Has Results
  • Jansky-Bielschowsky Disease
  • +4 more
  • BMN 190
  • Intracerebroventricular (ICV) access device
  • Columbus, Ohio
  • +3 more
Jul 28, 2022

Growth Hormone Deficiency Trial in Santiago (LUM-201)

Recruiting
  • Growth Hormone Deficiency
  • Santiago, Chile
    Institute of Maternal and Child Research, University of Chile
Jul 12, 2022